The Middle East Veterinary Vaccines Industry, with a valuation of US$ 335.0 Million in 2021, is poised for substantial growth, projected to achieve US$ 533.4 Million by 2031. This growth reflects a cumulative Compound Annual Growth Rate (CAGR) of 4.8% throughout the forecast period spanning from 2022 to 2031, as per the comprehensive study conducted by …
Category Archives: Healthcare Trends
Branded Generics Industry Forecasted to Achieve a 8.6% CAGR, Reaching US$747.2 Million by 2033
In 2023, the dynamic world of the branded generics industry will be valued at an impressive US$327.8 million. Looking ahead, the branded generics sector is set to skyrocket to an estimated US$747.2 million by 2033, boasting a compelling CAGR of 8.6% throughout the forecast period. Branded generics represent the latest incarnations of off-patent pharmaceuticals, masterfully crafted by …
Empty Capsules Industry’s Remarkable Journey Towards US$4.9 Billion in 2033 | Reveals by FMI
The global market for empty capsules is on a promising growth trajectory, with projected sales set to reach an impressive US$2.3 billion by 2023. This expansion is expected to persist with a steady compound annual growth rate (CAGR) of 7.9% from 2023 to 2033, culminating in a market value of US$4.9 billion. The surging demand for empty …
Global Peptide Therapeutics Industry on a Steady Upward Trajectory: Exploring the 10.8% CAGR and US$106 Billion Outlook for 2023 to 2033 | FMI Insights
The Global Peptide Therapeutics Industry has surged to a staggering valuation of US$38 billion in 2023 and is poised to reach an impressive US$106 billion by 2033. This remarkable growth is being driven by a robust compound annual growth rate (CAGR) of 10.8% over the forecast period. Notably, peptide therapeutics currently dominate 53.7% of the …
Oncolytic Adenovirus Market Targets US$ 250 Billion Valuation by 2033 | Future Market Insights,Inc.
During the forecast period 2023 to 2033, the oncolytic adenovirus market is expected to grow at a value of 7.5% CAGR, according to Future Market Insights. By the year 2033, the global market for oncolytic adenovirus is expected to rise up to a market valuation of US$ 250 Billion. Growth of the market can be attributed to …
Vaginal and Vulval Inflammatory Diseases Treatment Market Projected to Reach US$ 5.21 Billion by 2033 | Future Market Insights,Inc.
It is anticipated that the inflammatory disorders of the vaginal and vulval inflammatory diseases treatment market would grow from US$ 2.8 billion in fiscal year 2022 to US$ 2.96 billion in fiscal year 2023. Between 2023 and 2033, the global market is anticipated to expand at a 5.8% CAGR, peaking at US$ 5.21 billion by the …
Transfusion Dependent Thalassaemia Management Market Seeks 6% CAGR Growth Through 2033 Amid Rising Demand | Future market Insights,Inc.
The global Transfusion Dependent Thalassaemia Management Market is anticipated to reach a market value of US$ 10 Million in 2023 and to reach US$ 17.91 Million by registering a CAGR of 6% from 2023 to 2033. In the historical period from 2018 to 2022, the market for Transfusion Dependent Thalassaemia Management experienced a 4% CAGR. Studies state …
PPG Biosensors Market Sets Sights on US$ 1.9 Billion Valuation by 2033| Future Market Insights,Inc.
According to the newly released PPG Biosensors Market study report from Future Market Insights, the global market size of PPG biosensors in 2022 will be US$ 473 Million. The market is expected to be worth US$ 1.9 billion by 2033, growing at a CAGR of 15.2% between 2023 and 2033. With a CAGR of more than 17.1 …
Fucosidosis Therapeutics Market Targets US$ 17.91 Million by 2033 with a 6% CAGR | Future Market Insights,Inc.
With a CAGR of 6% from 2023 to 2033, the global Fucosidosis Therapeutics Market sales is anticipated to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033. The Fucosidosis Therapeutics market increased at a 4% CAGR between 2018 and 2022. According to studies, fucosidosis is a rare autosomal recessive lysosomal storage illness marked …
Drug Eruptions Treatment Market Projected to Reach US$ 7.1 Billion by 2033 | Future market Insights,Inc.
In fiscal year 2023, the global Drug Eruptions Treatment Market revenue is expected to be worth US$ 3.89 billion, up from US$ 3.66 billion in fiscal year 2022. The global market is expected to grow at a 6.2% CAGR from 2023 to 2033, reaching US$ 7.1 billion by the end of that year. A drug rash is …